Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dabigatran: how the drug company withheld important analyses.

× No keyword cloud information.

31 in total

1. Newer oral anticoagulants.

Authors: A N Robinson; C Scully
Journal: Br Dent J Date: 2015-03-13 Impact factor: 1.626

Review 2. New Oral Anticoagulants and Their Reversal Agents.

Authors: Andrea Morotti; Joshua N Goldstein
Journal: Curr Treat Options Neurol Date: 2016-11 Impact factor: 3.598

Review 3. Reversal Strategies for NOACs: State of Development, Possible Clinical Applications and Future Perspectives.

Authors: Steen Husted; Freek W A Verheugt; Willemijn J Comuth
Journal: Drug Saf Date: 2016-01 Impact factor: 5.606

4. The hazards of rapid approval of new drugs.

Authors: Jennifer Martin; Gillian Shenfield
Journal: Aust Prescr Date: 2016-02-01

Review 5. Regulatory, legislative, and policy updates with anticoagulant use.

Authors: John Fanikos; Leo F Buckley; Ahmed Aldemerdash; Kimberly J Terry; Gregory Piazza; Jean M Connors; Samuel Z Goldhaber
Journal: J Thromb Thrombolysis Date: 2015-04 Impact factor: 2.300

6. GI Bleeding Risk of DOACs Versus Warfarin: Is Newer Better?

Authors: Linda A Feagins; Rick A Weideman
Journal: Dig Dis Sci Date: 2018-07 Impact factor: 3.199

7. Serum Concentrations and Elimination Rates of Direct-Acting Oral Anticoagulants (DOACs) in Older Hip Fracture Patients Hospitalized for Surgery: A Pilot Study.

Authors: Kirsten K Viktil; Ina Lehre; Anette H Ranhoff; Espen Molden
Journal: Drugs Aging Date: 2019-01 Impact factor: 3.923

8. Emergency reversal of dabigatran for emergency surgery.

Authors: Thomas Puttick; Rahul Bahl; Hussein Mohamedbhai
Journal: BMJ Case Rep Date: 2015-04-29

9. Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017.

Authors: Junya Zhu; G Caleb Alexander; Saman Nazarian; Jodi B Segal; Albert W Wu
Journal: Pharmacotherapy Date: 2018-07-26 Impact factor: 4.705

10. The criteria of the Italian Federation of Thrombosis Centres on DOACs: a "real world" application in nonvalvular atrial fibrillation patients already on vitamin K antagonist.

Authors: Doris Barcellona; Miro Luzza; Nicola Battino; Lara Fenu; Francesco Marongiu
Journal: Intern Emerg Med Date: 2014-12-09 Impact factor: 3.397